SIREN : 795309525
ARCHIMED SAS is a French company founded 12 years ago, specialized in the sector Gestion de fonds. Based in LYON (69003), this company of category ETI shows in 2020 a revenue of 24.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 24 091 512 € | 14 245 198 € | 7 374 445 € | 2 920 605 € | 2 919 430 € | 3 378 820 € | 730 182 € |
| Net income | 10 435 254 € | 2 618 203 € | 605 296 € | 97 621 € | 106 088 € | 353 658 € | 226 425 € |
| EBITDA | 3 498 334 € | 3 774 073 € | 765 849 € | 138 641 € | 237 060 € | 569 121 € | -670 917 € |
| Net margin | 43.3% | 18.4% | 8.2% | 3.3% | 3.6% | 10.5% | 31.0% |
In 2020, ARCHIMED SAS achieves revenue of 24.1 M€. Over the period 2014-2020, the company shows strong growth with a CAGR (compound annual growth rate) of +79.1%. Vs 2019, growth of +69% (14.2 M€ -> 24.1 M€). After deducting consumption (222 €), gross margin stands at 24.1 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3.5 M€, representing 14.5% of revenue. Warning negative scissor effect: despite revenue change (+69%), EBITDA varies by -7%, reducing margin by 12.0 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 10.4 M€, i.e. 43.3% of revenue. This profit can be retained or distributed to shareholders.
24 091 512 €
24 091 290 €
3 498 334 €
3 245 923 €
10 435 254 €
14.5%
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.4 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 46.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
26.949%
41.033%
46.007%
0.355
60.7%
In 2020, the debt ratio of ARCHIMED SAS (26.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2020, the financial autonomy of ARCHIMED SAS (41.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2020, the repayment capacity of ARCHIMED SAS (0.35) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 143.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.7x. Coverage is limited: any activity downturn would jeopardize interest payments.
143.599
1.719
In 2020, the liquidity ratio of ARCHIMED SAS (143.60) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2020, the interest coverage of ARCHIMED SAS (1.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 26 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 137 days. Excellent situation: suppliers finance 111 days of the operating cycle (retail model). WCR is negative (-98 days): operations structurally generate cash. Notable WCR improvement over the period (-1127%), freeing up cash.
-6 551 446 €
26 j
137 j
0 j
-98 j
Based on 54 transactions of similar company sales
in 2020,
the value of ARCHIMED SAS is estimated at
27 823 280 €
(range 12 738 220€ - 51 817 976€).
With an EBITDA of 3 498 334€, the sector multiple of 4.2x is applied.
The price/revenue ratio is 0.66x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ARCHIMED SAS with other companies in the same sector:
The revenue of ARCHIMED SAS in 2020 is 24.1 M€.
Yes, ARCHIMED SAS generated a net profit of 10.4 M€ in 2020.
The headquarters of ARCHIMED SAS is located in LYON (69003), in the department Rhone.
The tax return of ARCHIMED SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ARCHIMED SAS operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.